2018-2023 Global Atorvastatin Calcium Consumption Market Report
NxtGen Reports recently added a new market research report in its offerings titled, "2018-2023 Global Atorvastatin Calcium Consumption Market Report".
(EMAILWIRE.COM, October 25, 2018 ) This report covers the present scenario (with the base year being 2017) and the growth prospects of global Atorvastatin Calcium market for 2018-2023.
Atorvastatin calcium is a pharmaceutical raw material in the production of atorvastatin calcium drug (trade name: Lipitor), which is a prescription medicine that lowers the LDL cholesterol and triglycerides in the blood and can raise HDL cholesterol as well. Atorvastatin calcium usually is white powder and whose CAS number is 134523-03-8.
Atorvastatin calcium refers to a pharmaceutical raw material in the production of atorvastatin calcium drug. It contains chemical synthesis type and biocatalysis type. The atorvastatin calcium industry is a concentrated group relatively, as production qualification of atorvastatin calcium is controlled by government.
India and China are the main consumption bases, and India holds 35.39% consumption share, and China holds 18.98% consumption share in 2015. They occupy 54.37% of the global consumption in total.
Over the next five years, this report projects that Atorvastatin Calcium will register a 7.0% CAGR in terms of revenue, reach US$ 230 million by 2023, from US$ 160 million in 2017.
This report presents a comprehensive overview, market shares, and growth opportunities of Atorvastatin Calcium market by product type, application, key manufacturers and key regions.
To calculate the market size, this report considers value and volume generated from the sales of the following segments:
Segmentation by product type:
Chemical Synthesis
Biocatalysis
Others
Segmentation by application:
Tablet (Including Dispersible Tablet and General Tablet)
Capsule
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
Pfizer
DSM Sinochem Pharmaceuticals
Cadila Pharmaceuticals
Sun Pharmaceutical Industries
Dr. Reddy’s
Morepen
Teva Pharmaceutical Industries
Apotex Pharmachem
Sandoz Inc
Mylan Pharmaceuticals Inc.
Kremers Urban Pharmaceuticals Inc.
ScieGen Pharmaceuticals, Inc.
Zheijang Neo-Dankon Pharmaceutical
Ningbo Menovo Pharmaceuticals Group
Jialin Pharmaceutical
Topfond
Zhejiang Hisun Pharmacutical
Zhejiang Hongyuan Pharmaceutical
Hubei Yitai Pharmaceutical
Jiangsu Hengrui Medicine
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Atorvastatin Calcium consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Atorvastatin Calcium market by identifying its various subsegments.
Focuses on the key global Atorvastatin Calcium manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Atorvastatin Calcium with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Atorvastatin Calcium submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
To get Free Sample or to Buy this report at discounted price visit: https://www.nxtgenreports.com/market-research-reports/2018-2023-global-atorvastatin-calcium-consumption
If you have any special requirements, kindly Contact Us and we will offer you the report as you want.
About NxtGen Reports: NxtGen Reports delivers strategic market research reports, industry analysis, business research and forecasts on product, services and companies. We understand the need of our customers and keep our market research reports up to date. Our reports are very well organized enabling our customers to identify and get access easily. We also offer customized discounts based on your expectations.
Contact Information:
Madhuri Vetal
NxtGen Reports
Email: sales@nxtgenreports.com
Phone: +918551022388
More Report at: https://www.nxtgenreports.com/market-research-reports
Atorvastatin calcium is a pharmaceutical raw material in the production of atorvastatin calcium drug (trade name: Lipitor), which is a prescription medicine that lowers the LDL cholesterol and triglycerides in the blood and can raise HDL cholesterol as well. Atorvastatin calcium usually is white powder and whose CAS number is 134523-03-8.
Atorvastatin calcium refers to a pharmaceutical raw material in the production of atorvastatin calcium drug. It contains chemical synthesis type and biocatalysis type. The atorvastatin calcium industry is a concentrated group relatively, as production qualification of atorvastatin calcium is controlled by government.
India and China are the main consumption bases, and India holds 35.39% consumption share, and China holds 18.98% consumption share in 2015. They occupy 54.37% of the global consumption in total.
Over the next five years, this report projects that Atorvastatin Calcium will register a 7.0% CAGR in terms of revenue, reach US$ 230 million by 2023, from US$ 160 million in 2017.
This report presents a comprehensive overview, market shares, and growth opportunities of Atorvastatin Calcium market by product type, application, key manufacturers and key regions.
To calculate the market size, this report considers value and volume generated from the sales of the following segments:
Segmentation by product type:
Chemical Synthesis
Biocatalysis
Others
Segmentation by application:
Tablet (Including Dispersible Tablet and General Tablet)
Capsule
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
Pfizer
DSM Sinochem Pharmaceuticals
Cadila Pharmaceuticals
Sun Pharmaceutical Industries
Dr. Reddy’s
Morepen
Teva Pharmaceutical Industries
Apotex Pharmachem
Sandoz Inc
Mylan Pharmaceuticals Inc.
Kremers Urban Pharmaceuticals Inc.
ScieGen Pharmaceuticals, Inc.
Zheijang Neo-Dankon Pharmaceutical
Ningbo Menovo Pharmaceuticals Group
Jialin Pharmaceutical
Topfond
Zhejiang Hisun Pharmacutical
Zhejiang Hongyuan Pharmaceutical
Hubei Yitai Pharmaceutical
Jiangsu Hengrui Medicine
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Atorvastatin Calcium consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Atorvastatin Calcium market by identifying its various subsegments.
Focuses on the key global Atorvastatin Calcium manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Atorvastatin Calcium with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Atorvastatin Calcium submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
To get Free Sample or to Buy this report at discounted price visit: https://www.nxtgenreports.com/market-research-reports/2018-2023-global-atorvastatin-calcium-consumption
If you have any special requirements, kindly Contact Us and we will offer you the report as you want.
About NxtGen Reports: NxtGen Reports delivers strategic market research reports, industry analysis, business research and forecasts on product, services and companies. We understand the need of our customers and keep our market research reports up to date. Our reports are very well organized enabling our customers to identify and get access easily. We also offer customized discounts based on your expectations.
Contact Information:
Madhuri Vetal
NxtGen Reports
Email: sales@nxtgenreports.com
Phone: +918551022388
More Report at: https://www.nxtgenreports.com/market-research-reports
Contact Information:
NxtGen Reports
Madhuri Vetal
Tel: +918551022388
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
NxtGen Reports
Madhuri Vetal
Tel: +918551022388
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results